{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:20:47Z","timestamp":1791051647166,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1981,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1593\/neo.08784","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:06:51Z","timestamp":1429794411000},"page":"1362-IN9","source":"Crossref","is-referenced-by-count":78,"title":["Neurofibromin 1 (NF1) Defects Are Common in Human Ovarian Serous Carcinomas and Co-occur with TP53 Mutations"],"prefix":"10.1016","volume":"10","author":[{"given":"Navneet","family":"Sangha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rork","family":"Kuick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Fiander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Katabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.08784_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1593\/neo.08784_bib2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","article-title":"Inactivation of BRCA1 and BRCA2 in ovarian cancer","volume":"94","author":"Hilton","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.08784_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.1507","article-title":"Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene","volume":"202","author":"Wang","year":"2004","journal-title":"J Pathol"},{"key":"10.1593\/neo.08784_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.10181","article-title":"TP53 and ovarian cancer","volume":"21","author":"Schuijer","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib5","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1593\/neo.08784_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.humpath.2006.10.007","article-title":"Alternate molecular genetic pathways in ovarian carcinomas of common histological types","volume":"38","author":"Willner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1593\/neo.08784_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1593\/neo.08784_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"10.1593\/neo.08784_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1593\/neo.08784_bib10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.287.13.1671","article-title":"Osteopontin as a potential diagnostic biomarker for ovarian cancer","volume":"287","author":"Kim","year":"2002","journal-title":"JAMA"},{"key":"10.1593\/neo.08784_bib11","first-page":"3668","article-title":"Comparative properties of five human ovarian adenocarcinoma cell lines","volume":"45","author":"Buick","year":"1985","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08784_bib12","first-page":"6358","article-title":"Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease","volume":"51","author":"Masazza","year":"1991","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08784_bib13","first-page":"6166","article-title":"Characterization and properties of nine human ovarian adenocarcinoma cell lines","volume":"48","author":"Langdon","year":"1988","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08784_bib14","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1101\/gr.1349003","article-title":"Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation","volume":"13","author":"Lucito","year":"2003","journal-title":"Genome Res"},{"key":"10.1593\/neo.08784_bib15","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.0708286104","article-title":"Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer","volume":"104","author":"Kendall","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.08784_bib16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0002-9440(10)64294-0","article-title":"Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas","volume":"162","author":"Wu","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.08784_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/hmg\/4.6.975","article-title":"Distribution of 13 truncating mutations in the neurofibromatosis 1 gene","volume":"4","author":"Heim","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1593\/neo.08784_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/gte.2006.10.8","article-title":"Combinatorial sequencing-byhybridization: analysis of the NF1 gene","volume":"10","author":"Schirinzi","year":"2006","journal-title":"Genet Test"},{"key":"10.1593\/neo.08784_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00439-002-0858-4","article-title":"Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type","volume":"112","author":"Wang","year":"2003","journal-title":"Hum Genet"},{"key":"10.1593\/neo.08784_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0888-7543(95)80104-T","article-title":"Genomic organization of the neurofibromatosis 1 gene (NF1)","volume":"25","author":"Li","year":"1995","journal-title":"Genomics"},{"key":"10.1593\/neo.08784_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(02)02887-9","article-title":"Quantification of NF1 transcripts reveals novel highly expressed splice variants","volume":"522","author":"Vandenbroucke","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1593\/neo.08784_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/MCB.12.3.1149","article-title":"Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products","volume":"12","author":"Lim","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1593\/neo.08784_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004390100594","article-title":"Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene","volume":"109","author":"Han","year":"2001","journal-title":"Hum Genet"},{"key":"10.1593\/neo.08784_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/humu.9018","article-title":"NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas","volume":"19","author":"Kluwe","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s004399900135","article-title":"Evaluation of the protein truncation test and mutation detection in the NF1 gene: mutational analysis of 15 known and 40 unknown mutations","volume":"105","author":"Osborn","year":"1999","journal-title":"Hum Genet"},{"key":"10.1593\/neo.08784_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/humu.20103","article-title":"Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1","volume":"24","author":"Zatkova","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib27","first-page":"1503","article-title":"Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2","volume":"62","author":"Kaufmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08784_bib28","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.88.22.9914","article-title":"Identification and characterization of the neurofibromatosis type 1 protein product","volume":"88","author":"DeClue","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.08784_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/356663a0","article-title":"Ras regulation. NF is enough of GAP","volume":"356","author":"Bollag","year":"1992","journal-title":"Nature"},{"key":"10.1593\/neo.08784_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"key":"10.1593\/neo.08784_bib31","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene"},{"key":"10.1593\/neo.08784_bib32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","article-title":"Diverse tumorigenic pathways in ovarian serous carcinoma","volume":"160","author":"Singer","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.08784_bib33","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.08784_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004347-200301000-00009","article-title":"Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor)","volume":"22","author":"Singer","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1593\/neo.08784_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.08784_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1593\/neo.08784_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1593\/neo.08784_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1593\/neo.08784_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1593\/neo.07304","article-title":"MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors","volume":"9","author":"Holtkamp","year":"2007","journal-title":"Neoplasia"},{"key":"10.1593\/neo.08784_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.20601","article-title":"Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)","volume":"29","author":"Upadhyaya","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/9.2.237","article-title":"Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1","volume":"9","author":"Ars","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1593\/neo.08784_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib43","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J Med Genet"},{"key":"10.1593\/neo.08784_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/humu.20493","article-title":"Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5\u2032 splice-site disruption","volume":"28","author":"Wimmer","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.08784_bib46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cc.3.10.1182","article-title":"Ras\/Raf\/ERK signalling and NF1","volume":"3","author":"Harrisingh","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1593\/neo.08784_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"key":"10.1593\/neo.08784_bib48","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1093\/hmg\/10.26.3009","article-title":"Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes","volume":"10","author":"Gutmann","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1593\/neo.08784_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.194.1.57","article-title":"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro","volume":"194","author":"Ingram","year":"2001","journal-title":"J Exp Med"},{"key":"10.1593\/neo.08784_bib50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0002-9440(10)65322-9","article-title":"Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro","volume":"154","author":"Aaltonen","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.08784_bib51","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1073\/pnas.90.12.5539","article-title":"Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras","volume":"90","author":"Johnson","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.08784_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/gut.2004.053348","article-title":"NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer","volume":"54","author":"Cacev","year":"2005","journal-title":"Gut"},{"key":"10.1593\/neo.08784_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s005950300074","article-title":"Novel mutations of neurofibromatosis type 1 gene in small cell lung cancers","volume":"33","author":"Furukawa","year":"2003","journal-title":"Surg Today"},{"key":"10.1593\/neo.08784_bib54","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1593\/neo.08312","article-title":"RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and\/or RASSF1A","volume":"10","author":"Ahlquist","year":"2008","journal-title":"Neoplasia"},{"key":"10.1593\/neo.08784_bib55","first-page":"138","article-title":"Ovarian cancer in a female patient with von Recklinghausen's disease","volume":"96","author":"Salud","year":"1991","journal-title":"Med Clin (Barc)"},{"key":"10.1593\/neo.08784_bib56","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0002-9378(95)90020-9","article-title":"Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer","volume":"172","author":"Schildkraut","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1593\/neo.08784_bib57","first-page":"2147","article-title":"Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors","volume":"12","author":"Wertheim","year":"1996","journal-title":"Oncogene"},{"key":"10.1593\/neo.08784_bib58","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-04-0893","article-title":"Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas","volume":"10","author":"Hsu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.08784_bib59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/humu.10181","article-title":"TP53 and ovarian cancer","volume":"21","author":"Schuijer","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1593\/neo.08784_bib60","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1073\/pnas.90.11.4961","article-title":"p53 gene mutations and protein accumulation in human ovarian cancer","volume":"90","author":"Kupryjanczyk","year":"1993","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558608800814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558608800814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:14:35Z","timestamp":1598944475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558608800814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1476558608800814"],"URL":"https:\/\/doi.org\/10.1593\/neo.08784","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}